For instance, PDAC can promote tumor progression through non-VEGF-dependent angiogenesis, mediated by the Bicaudal C Homolog 1/Lipocalin 2 axis, highlighting novel therapeutic targets for anti-angiogenic strategies. The gene discussed is VEGFA; the disease is neoplasm.